SCHEMBL5333394

SCHEMBL5333394

CC(Sc1cn(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2ccccc12)N(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 11/20 0.48
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
GLA P06280 1/20 0.40
HTT P42858 1/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
HTR1F P30939 1/20 0.39
HTR7 P34969 1/20 0.39
DRD3 P35462 1/20 0.39
CACNA1B Q00975 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5327029 0.88 HTR6 (0.49) HTR6ALDH1A1L3MBTL1GAAHPGD
SCHEMBL5330679 0.88 HTR6 (0.49) HTR6ALDH1A1L3MBTL1GAAHPGD
SCHEMBL5336517 0.85 HTR6 (0.58) HTR6L3MBTL1HTR1ADRD2HTR1D
SCHEMBL5330251 0.81 HTR6 (0.50) HTR6L3MBTL1HTR1ADRD2HTR1D
SCHEMBL5333397 0.80 HTR6 (0.53) HTR6ALDH1A1L3MBTL1GAAHPGD
SCHEMBL5330258 0.80 KDM4E (0.55) HTR6L3MBTL1HTR1ADRD2HTR1D
SCHEMBL5328011 0.80 HTR6 (0.52) HTR6ALDH1A1L3MBTL1GAAHPGD
SCHEMBL5330295 0.79 HTR6 (0.54) HTR6L3MBTL1HTR1ADRD2HTR1D
SCHEMBL5331226 0.78 HTR6 (0.57) HTR6HTR1ADRD2HTR1DHTR1B
SCHEMBL5330866 0.75 HTR6 (0.50) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007020653-A1 THIOETHER DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2007-02-22 WO disclosed